About RIGIMMUNE, INC.
RIGImmune Inc. is a biotechnology company formed in 2020 by Yale University professors Drs. Anna Marie Pyle and Akiko Iwasaki, focusing on the development of RNA therapeutics delivered directly to the respiratory tract using a non-LNP technology platform called NEED™.
Development of RNA therapeutics for respiratory diseasesNon-LNP delivery of RNA therapeutics via the NEED™ platformTargeted delivery of RNA to the respiratory tractResearch and development of stem loop RNA therapeutics (SLRs)Inhalation and mucosal delivery formulations for respiratory diseases
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RIGIMMUNE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.